Kang Li
-
- Cerebrovascular and Carotid Artery Diseases 9
- Ferroptosis and cancer prognosis 6
- Vascular Procedures and Complications 6
- Lung Cancer Treatments and Mutations 5
- Aortic aneurysm repair treatments 4
- Lung Cancer Diagnosis and Treatment 4
-
- Cancer, Lipids, and Metabolism 4
-
- Peripheral Artery Disease Management 6
- Co-authors
- Jingjing LiuNingning TaoHai BaiJian‐Feng OuDan ZengHui RenChongjie ZhangTieying Sun
- Journals
- SHILAP Revista de lepidopterología (1 paper)Scientific Reports (3 papers)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesPoland
In The Last Decade
Kang Li
46 papers receiving 451 citations
Peers
Comparison fields: 5 of 75
- Pulmonary and Respiratory Medicine 270
- Cancer Research 76
- Oncology 81
- Nephrology 21
- Molecular Biology 153
Countries citing papers authored by Kang Li
This map shows the geographic impact of Kang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang Li more than expected).
Fields of papers citing papers by Kang Li
This network shows the impact of papers produced by Kang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang Li. The network helps show where Kang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 21 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 24 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 25 | |
| 14 | 2020 | 1 | |
| 15 | 2020 | 13 | |
| 16 | 2020 | 7 | |
| 17 | 2019 | 19 | |
| 18 | 2018 | 19 | |
| 19 | 2018 | 2 | |
| 20 | 2016 | 6 |
About Kang Li
Kang Li is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Anesthesiology and Pain Medicine, having authored 51 papers that have together received 453 indexed citations. Recurring topics across this work include Cerebrovascular and Carotid Artery Diseases (9 papers), Ferroptosis and cancer prognosis (6 papers), Vascular Procedures and Complications (6 papers), Peripheral Artery Disease Management (6 papers), Lung Cancer Treatments and Mutations (5 papers), Aortic aneurysm repair treatments (4 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (270 citations), Cancer Research (76 citations) and Oncology (81 citations). Kang Li has collaborated with scholars based in China, United States and Poland. Frequent co-authors include Jingjing Liu, Ningning Tao, Hai Bai, Jian‐Feng Ou, Dan Zeng, Hui Ren, Chongjie Zhang, Tieying Sun, Zhiqiang Ma and Weixin Hu. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.